These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 61287)

  • 21. Sequential antilymphoblast globulin and cyclosporine for renal transplantation.
    Sommer BG; Henry ML; Ferguson RM
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1879-80. PubMed ID: 3274445
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical experience with antilymphocyte globulin (ALG) in renal transplantation.
    Deodhar SD; Konomi K; Nakamoto S; Kuruvila KC
    Transplant Proc; 1971 Mar; 3(1):758-61. PubMed ID: 4937968
    [No Abstract]   [Full Text] [Related]  

  • 23. Antibody response to horse gamma-globulin in recipients of renal allografts: relationship with transplant crises and transplant survival.
    Vincent C; Revillard JP
    Transplantation; 1977 Aug; 24(2):141-7. PubMed ID: 70872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nursing review of the use and administration of antilymphocyte globulin in renal transplantation.
    Downs SA
    J Am Assoc Nephrol Nurses Tech; 1981 Feb; 8(1):49-51. PubMed ID: 7009705
    [No Abstract]   [Full Text] [Related]  

  • 25. Canadian clinical trial of antilymphocyte globulin in human cadaver renal transplantation.
    Taylor HE; Ackman CF; Horowitz I
    Can Med Assoc J; 1976 Dec; 115(12):1205-8. PubMed ID: 793705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment with antilymphocyte globulin (ALG) and evolution of renal transplant: observations of 42 cases].
    Civati G; Grillo C; Di Belgioioso GB; Rovati C; Surian M; Busnach G; Broggi L; Ferrari L
    Boll Ist Sieroter Milan; 1978 May; 57(2):165-72. PubMed ID: 365193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Occurrence of ANTI-AHLG in renal transplant patients on AHLG (anti-human lymphocyte globulin).
    Konomi K; Ohta T; Toyoda K; Saito S; Fujimi S
    Jpn J Surg; 1980 Dec; 10(4):315-20. PubMed ID: 7012410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of immunologic tolerance to antilymphocyte globulin in man.
    Gewurz H; Moberg AW; Simmons RL; Pollara B; Gunnarsson A; Soll R; Najarian JS
    Surg Forum; 1969; 20():259-61. PubMed ID: 4986402
    [No Abstract]   [Full Text] [Related]  

  • 29. Antilymphoblastic globulin in renal transplant patients: no allergic reactions: a correction.
    Chou SN
    JAMA; 1995 Dec; 274(21):1676. PubMed ID: 7474270
    [No Abstract]   [Full Text] [Related]  

  • 30. The clinical use of antilymphocyte globulin.
    Najarian JS; Simmons RL
    N Engl J Med; 1971 Jul; 285(3):158-66. PubMed ID: 4103453
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunologic monitoring parameters in ALG- versus non-ALG-treated renal transplant patients.
    McAlack RF; Stern S; Beizer R; Sklar L; Bannett A
    Transplant Proc; 1979 Jun; 11(2):1431-2. PubMed ID: 382532
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pharmacodynamics of antilymphocyte globulin (ALG) in mice with skin allotransplants. I. Distribution and elimination of ALG-I-131 during single and multiple administration].
    Serebriakov NG; Suskova VS; Petrosova VN; Emets VI; Skriabina EG
    Vestn Akad Med Nauk SSSR; 1973; 28(8):77-81. PubMed ID: 4585260
    [No Abstract]   [Full Text] [Related]  

  • 33. Antilymphocyte globulin with a small dose of cyclosporine A and prednisone as the induction of immunosuppression in renal allograft recipients.
    Boratyńska M; Szepietowski T; Szewczyk Z; Szydłowski Z
    Arch Immunol Ther Exp (Warsz); 1992; 40(2):163-8. PubMed ID: 1299176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Adverse effects of anti-thymocyte globulin/anti-lymphocyte globulin therapy].
    Kobayashi R; Kaneda M; Watanabe N; Iguchi A; Cho Y; Yoshida M; Arioka H; Naito H; Shikano T; Ishikawa Y
    Rinsho Ketsueki; 1999 Jul; 40(7):531-5. PubMed ID: 10483134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antilymphoblast globulin for renal allograft prolongation.
    Simmons RL; Condie R; Najarian JS
    Transplant Proc; 1972 Dec; 4(4):487-90. PubMed ID: 4566792
    [No Abstract]   [Full Text] [Related]  

  • 36. Antilymphocyte globulin in renal transplantation: Nephrotic syndrome and infection as possible complications.
    Michel RP; Guttmann RD; Knaack J; Klassen J; Beudoin JG; Morehouse DD
    Arch Surg; 1975 Jan; 110(1):90-3. PubMed ID: 1090283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibodies against equine ALG during treatment of rejection crisis after renal allotransplantation.
    Birkeland SA; Munk-Andersen G
    Scand J Immunol; 1975; 4(4):369-72. PubMed ID: 1103274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical reactions and serologic changes after the administration of heterologous antilymphocyte globulin to human recipients of renal homografts.
    Kashiwagi N; Brantigan CO; Brettschneider L; Groth CG; Starzl TE
    Ann Intern Med; 1968 Feb; 68(2):275-86. PubMed ID: 4181614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antithymocyte globulin (ATG) dosage and graft survival in renal transplantation.
    Kountz SL; Butt KH; Rao TK; Zielinski CM; Rafi M; Schultz JR
    Transplant Proc; 1977 Mar; 9(1):1023-5. PubMed ID: 325728
    [No Abstract]   [Full Text] [Related]  

  • 40. Role of anti-idiotypic antibodies in sensitized patients awaiting renal transplantation.
    Ramounau-Pigot A; Mourad G; Cristol JP; Argiles A; Seignalet J
    Transplant Proc; 1992 Dec; 24(6):2496. PubMed ID: 1465843
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.